Doctor profile · Federal record
Dr. Samantha Carter, M.D.
Specialist (CMS: Dermatology) · Specialist · Katy, TX
- NPI 1073520839
- Accepts Medicare
- MIPS 100.0 / 100 · 2023
- 24 yrs in practice
- Licensed in 2 states
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
21310 Provincial Blvd
Katy, TX 774507580
(281) 599-0404
fax (281) 599-1655
Credentials & registration
- NPI registered
- August 2006 — 20 yrs on file
- Profile last updated
- October 26, 2010
- Year of graduation
- 2002 — 24 yrs since
- Specialty taxonomy
- 174400000X — NUCC code
- State licenses (2)
- Texas #M2578 · Arizona #35821
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1073520839. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
2,525
Distinct HCPCS
10
Medicare allowed
$159,695
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
17003 |
Destruction of precancer skin growth, 2-14 growths | 710 | 161 | $7 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 704 | 485 | $92 | |
17000 |
Destruction of precancer skin growth, 1 growth | 356 | 264 | $55 | |
11102 |
Biopsy of related skin growth, first growth | 250 | 210 | $102 | |
99212 |
Established patient office or other outpatient visit, 10-19 minutes | 110 | 97 | $57 | |
11103 |
Biopsy of related skin growth, each additional growth | 107 | 54 | $51 | |
99203 |
New patient office or other outpatient visit, 30-44 minutes | 98 | 98 | $114 | |
J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 26 | 19 | $1 | |
11900 |
Injection into skin growth, 1-7 growths | 25 | 18 | $50 | |
17110 |
Destruction of skin growth, 1-14 growths | 25 | 23 | $116 |
In context: peer comparison
Among 1 peers in this city , average services per provider: 157. This provider delivers 16× the peer median.Open Payments
Industry payments received
All-time total
$1,567
Transactions
77
Manufacturers
13
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Janssen Biotech, Inc. | 20 | $374.67 | |
| ABBVIE INC. | 15 | $348.58 | |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 7 | $174.69 | |
| Dermavant Sciences, Inc. | 9 | $158.51 | |
| Amgen Inc. | 6 | $126.60 | |
| Arcutis Biotherapeutics, Inc. | 5 | $104.04 | |
| LEO Pharma Inc. | 3 | $55.46 | |
| Lilly USA, LLC | 3 | $53.01 | |
| Galderma Laboratories, L.P. | 3 | $51.29 | |
| Novartis Pharmaceuticals Corporation | 2 | $43.41 | |
| Incyte Corporation | 2 | $40.26 | |
| E.R. Squibb & Sons, L.L.C. | 1 | $22.33 | |
| Verrica Pharmaceuticals Inc. | 1 | $14.22 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
682
Patients
413
Total drug cost
$21,555
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Ketoconazole | Generic | 236 | 127 | $6,281 |
| Triamcinolone Acetonide | Generic | 82 | 72 | $820 |
| Doxycycline Hyclate | Generic | 71 | 46 | $1,786 |
| Valacyclovir (Valacyclovir Hcl) | Brand | 44 | 17 | $2,090 |
| Hydrocortisone | Generic | 35 | 33 | $285 |
| Fluorouracil | Generic | 34 | 32 | $3,417 |
| Finasteride | Generic | 28 | 0 | $129 |
| Metronidazole | Generic | 28 | 24 | $2,037 |
| Clobetasol Propionate | Generic | 20 | 17 | $983 |
| Fluocinonide | Generic | 19 | 15 | $1,074 |
Frequently asked questions
What is Dr. Samantha Carter's medical specialty?
Dr. Samantha Carter practices Specialist in Katy, TX.
Where does Dr. Samantha Carter practice?
Dr. Samantha Carter practices at 21310 Provincial Blvd, Katy, TX 774507580. Office phone: 2815990404.
What is Dr. Samantha Carter's NPI?
Dr. Samantha Carter's National Provider Identifier (NPI) is 1073520839, issued by NPPES.
Does Dr. Samantha Carter accept Medicare assignment?
Yes. Dr. Samantha Carter accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Samantha Carter commonly perform?
Top Medicare-reported procedures in 2023: Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); Established patient office or other outpatient visit (HCPCS 99213); Destruction of precancer skin growth, 1 growth (HCPCS 17000). Source: CMS Medicare Physician & Other Practitioners file.